FDA
-
-
-
-
-
-
-
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
-
-
-
-
-
-
-
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
-
-
-
-
-
-
-
ProKidney Corp. (PROK) PT Raised to $9 at Citi
-
-
-
-
-
-
-
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
ProKidney Corp (PROK) Announces Strategic Updates to its Phase 3 Program
-
-
-
-
-
-
-
ProKidney Corp (PROK) Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
-
-
-
-
-
-
-
ProKidney Corp (PROK) Announces Leadership Changes
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


